Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01820299 · ClinicalTrials.gov registry record · Phase 1
Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer
A Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT01820299 is a Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 22 participants.
The verdict
NCT01820299, a Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
This study is for subjects with solid cancers (gastrointestinal, lung, breast, prostate, lymphoma or cancer of the lymph nodes). The overall goal of this study is to identify plant-derived phytochemicals that can safely reduce systemic inflammation (inflammation throughout the entire body) in subjects with advanced cancer.
Interventions
- DRUG Vitamin D
- DRUG Grape Seed Extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-03 |
| Est. Completion | 2016-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01820299
The ClinicalTrials.gov registry entry for NCT01820299 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin D is the first listed.
NCT01820299 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01820299 about?
NCT01820299 is a clinical study titled "Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer". This study is for subjects with solid cancers (gastrointestinal, lung, breast, prostate, lymphoma or cancer of the lymph nodes). The overall goal of this study is to identify plant-derived phytochemicals that can safely reduce systemic inflammation (inflammation throughout the entire body) in subjec...
What is the current status of trial NCT01820299?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2013-03. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01820299?
The interventions under investigation include: Vitamin D (DRUG), Grape Seed Extract (DRUG).
Who is sponsoring clinical trial NCT01820299?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.